Feb. 10, 2023
A Billion-Dollar Aldosterone Synthase Inhibitor, an Oral KRASG12D Inhibitor Entering Development, and 14 More Molecules in the News
Welcome to Phase III of Drug Hunter! Pardon our dust and please report any issues you encounter to support@drughunter.com.